Single-cycle Remote Ischemic Preconditioning and Postconditioning (SCRIP) Trial
NCT ID: NCT02649309
Last Updated: 2018-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
370 participants
INTERVENTIONAL
2015-10-31
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sodium Thiosulfate to Preserve Cardiac Function in STEMI
NCT02899364
Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction
NCT02164695
Remote Ischemic Conditioning With Local Ischemic Postconditioning in High-Risk ST-elevation Myocardial Infarction
NCT04844931
Long-term Remote Ischemic Preconditioning Improve Long-term Prognosis of Acute Myocardial Infarction Patients Without Emergency Reperfusion Therapy
NCT02843464
Myocardial Infarction Triage and Intervention Project (MITI)
NCT00000468
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RIPre + RIPost
Intervention: RIPre 200 mmHg + RIPost 200 mmHg
RIPre
Preconditioning 200 mmHg x 5 minutes before procedure
RIPost
Postconditioning 200 mmHg x 5 minutes after procedure
RIPre + Sham
Intervention: RIPre 200 mmHg + Sham 10 mmHg
RIPre
Preconditioning 200 mmHg x 5 minutes before procedure
Sham-Post
Sham 10 mmHg x 5 minutes after procedure
Sham + RIPost
Intervention: Sham 10 mmHg + RIPost 200 mmHg
Sham-Pre
Sham 10 mmHg x 5 minutes before procedure
RIPost
Postconditioning 200 mmHg x 5 minutes after procedure
Sham + Sham
Intervention: Sham 10 mmHg + Sham 10 mmHg
Sham-Pre
Sham 10 mmHg x 5 minutes before procedure
Sham-Post
Sham 10 mmHg x 5 minutes after procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RIPre
Preconditioning 200 mmHg x 5 minutes before procedure
Sham-Pre
Sham 10 mmHg x 5 minutes before procedure
RIPost
Postconditioning 200 mmHg x 5 minutes after procedure
Sham-Post
Sham 10 mmHg x 5 minutes after procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18-year-old
* Informed consent
Exclusion Criteria
* Previous PCI in 1 week / treatment with thrombolysis within 30 days
* Peripheral arterial disease / A-V shunt of upper extremities (AVF for hemodialysis)
* Paresis of upper limb
* Unstable patient such as cardiogenic shock / vasopressor / IABP / cooling (hypothermia)
* Fatal cardiac arrhythmia (VT / VF)
* Chronic hypoxia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Phramongkutklao College of Medicine and Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nakarin Sansanayudh, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Internal Medicine, Phramongkutklao Hospital, Bangkok, Thailand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Internal Medicine
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PMK-SCRIP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.